width=With a research grant from the A-TCP, Ronald Hart, PhD at Rutgers University in New Jersey will create induced pluripotent stem cells (iPSCs) using blood samples taken from kids with A-T. Disease-specific iPSCs are often called “disease in a dish” models, because they allow scientists to study a disease using cells in culture, outside of a human or animal body.

Especially exciting, with the right stimulation, it may be possible to turn the iPSCs into brain cells, providing a way for neuroscientists to learn more about how A-T affects the brain. In addition, iPSCs can be used to screen chemical compounds for potential new drugs.

Oops! We could not locate your form.

Related News

Apr 11 @ 4:58 am

Lost Cleveland Memories’ 500th Presentation for the A-TCP!

Dennis has turned his love of history and storytelling into Lost Cleveland Memories, an incredibly successful fundraising effort

more
Apr 11 @ 4:58 am

Race with the A-T CureTeam at Disney!

Announcing the CureTeam's Walt Disney World race schedule!

more
Apr 11 @ 4:58 am

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
Apr 11 @ 4:58 am

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more